Off-Label Use Of Risky Antipsychotic Drugs Raises Concerns
By Sandra G. Boodman, for Kaiser Health News, March 12, 2012 This story was produced in collaboration with The Washington Post. Adriane Fugh-Berman was stunned by the question: Two graduate students who had no symptoms of mental illness wondered if she thought they should take a powerful schizophrenia drug each had been prescribed to treat […]